JD Supra

MoFo BioMeter - Vol. 3, Issue 2, May 2014 - Early Stage Deals Dominant Q1: Uptick in total dealmaking activity compared with same quarter last year

The MoFo BioMeter for the first quarter of 2014 shows a decrease in average BioMeter value in a quarter dominated by early stage deals. Total dealmaking activity showed an uptick compared to the same ...
JD Supra

MoFo BioMeter - Vol. 2, Issue 3, August 2013 - Q2 BioMeter Encouraging for Products from Early Development through Phase 2

The average BioMeter value in the second quarter of 2013 was $22.2 million, an increase from the $16.3 million value in the first quarter (excluding BMS/Rickets and AZ/Moderna), and down from $59.4 ...
The Business Journals

Introducing the BioMeter

In late 2012, Morrison & Foerster launched the BioMeter™, a quarterly index that measures the health of the biotechnology industry. The BioMeter averages up-front payments in licensing, collaboration, ...
MM&M

BioMeter analyzes data from deals

Law firm Morrison & Foerster launched a new quarterly publication, MoFo Biometer, that indexes average up-front payments in licensing, collaboration, and development agreements between biotechnology ...